Skip to content
FrontierPicks

Covered

BLKB · Blackbaud

Conviction · Low · more likely to lag the S&P 500 over the next three months

Wrong if: a daily close above $64.30

Note written ·

Price against the kill line

15.8% clear of its kill line on the 13 November 2026 close.

How to read this

This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

BLKBBlackbaud
$64.30
$54.15
15.8%well clear

Three months against the kill line

BLKB daily closes from 17 August 2026 to 13 November 2026, last $54.15, against its kill line: a daily close above $64.30. 17 August 2026: $43.3918 August 2026: $44.3619 August 2026: $46.1620 August 2026: $46.4021 August 2026: $47.5224 August 2026: $48.0725 August 2026: $47.4226 August 2026: $47.0927 August 2026: $48.5728 August 2026: $48.6231 August 2026: $48.061 September 2026: $47.782 September 2026: $47.473 September 2026: $48.464 September 2026: $47.108 September 2026: $45.269 September 2026: $44.0710 September 2026: $44.2211 September 2026: $45.4814 September 2026: $45.6715 September 2026: $45.0816 September 2026: $44.8217 September 2026: $43.3418 September 2026: $42.8521 September 2026: $43.0422 September 2026: $42.1323 September 2026: $42.8924 September 2026: $43.2725 September 2026: $43.1928 September 2026: $42.3629 September 2026: $41.4330 September 2026: $41.621 October 2026: $42.552 October 2026: $41.765 October 2026: $43.316 October 2026: $43.517 October 2026: $44.528 October 2026: $44.849 October 2026: $45.4812 October 2026: $46.7513 October 2026: $48.0614 October 2026: $48.8615 October 2026: $51.3916 October 2026: $51.6519 October 2026: $53.2420 October 2026: $53.5721 October 2026: $53.6822 October 2026: $56.4823 October 2026: $55.5426 October 2026: $55.0727 October 2026: $53.7028 October 2026: $52.5129 October 2026: $52.7130 October 2026: $53.552 November 2026: $54.443 November 2026: $54.214 November 2026: $56.065 November 2026: $55.806 November 2026: $54.129 November 2026: $54.5810 November 2026: $54.9211 November 2026: $54.4012 November 2026: $53.5613 November 2026: $54.15

Daily closes, to . Red: the kill line, a daily close above $64.30, on record since 11 November 2026. The shares are up 24.8% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close above $64.30, just under the 52-week intraday high of $64.84 on 17 December 2025, which would show the shares leading the S&P 500. Fourth-quarter 2026 organic revenue growth above the 4.1% of the third quarter, with a 2027 revenue guide faster than 2026, would also show it.

Research onlyNot in the portfolio.

The portfolio's record →

Key figures from the filings · Technology

Quarter to 30 September 2026, filed 28 October 2026; valuation at the 13 November 2026 close

Revenue, latest quarter ($M)
293
Revenue, change on a year (%)
+4.1
Gross margin (%)
60.8
Operating margin (%)
20.5
Free cash flow, four quarters ($M)
332
Net cash, cash less debt ($M)
−1,009
Price to earnings (×)
16.3
Enterprise value to sales (×)
3.0
All filed numbers

What Blackbaud reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 293 +4.1 60.8 20.5
first filed 291 +3.0 61.3 21.3
first filed 281 +4.2 59.2 18.3
first filed 295 −2.3 58.4 20.0
first filed 281 −1.9 59.6 19.4
first filed restated 282 −1.8 59.7 20.3
Income Quarter to 30 September 2026, filed 28 October 2026
Pre-tax income ($M) 46.4
Net income ($M) four quarters: 149 46.1
Diluted shares, change on a year (%) against the quarter to 30 September 2025 −7.3
Cash flow Four quarters to 30 September 2026, filed 28 October 2026
Operating cash flow ($M) 342
Capital spending ($M) 10.3
Free cash flow ($M) 332
Balance sheet At 30 September 2026, filed 28 October 2026
Cash and short-term investments ($M) 35.7
Debt ($M) non-current long-term debt plus current maturities 1,045
Net cash, cash less debt ($M) −1,009
Deferred revenue ($M) −0.1% on a year 385
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) 76.2
Inventory ($M) Not reported
Shareholders' equity ($M) 120
Valuation At the 13 November 2026 close, filed figures to 28 October 2026
Market value ($M) 2,436
Enterprise value, market value plus net debt ($M) 3,445
Enterprise value to sales (×) 3.0
Enterprise value to operating income (×) 14.8
Price to earnings (×) 16.3
Price to book value (×) 20.4
Free-cash-flow yield (%) 13.6

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 7.5% of shares outstanding sold short, 8.0 days of average trading to cover, +0.5% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $2.0M
12 monthsfrom $0 $5.9M

The thesis

Blackbaud's shares are more likely to lag the S&P 500 over the next three months. The third-quarter report on 28 October 2026 held the upper-half 2026 outlook, but management expects a renewal cohort about 40% larger than 2025's to slow contract growth through the first half of 2027. The fourth-quarter report and first 2027 guide, estimated for around 10 February 2027, settle whether growth holds through that cycle.

The third quarter removed a near-term worry. Non-GAAP organic revenue grew 4.1%, up from 3.0% in the second quarter, and Blackbaud reaffirmed 2026 revenue of $1.173–1.179 billion. Revenue of $292.6 million still came in under Benzinga's $293.935 million consensus, while non-GAAP earnings per share (EPS) of $1.36 beat the $1.33 estimate. A smaller share count helped the EPS result.

The market has already paid for the recovery. The shares closed at $53.56 on 12 November 2026, up 18.4% over three months and well above the 200-day average of $41.22. No dated catalyst falls inside the next 30 days.

Bullish and bearish views on Blackbaud, Inc.

The bull case on Blackbaud, Inc. (BLKB), in brief: organic growth recovered in the third quarter. The bear case: a larger renewal cohort slows contract growth.

Bull case

  • Organic growth recovered in the third quarter. Non-GAAP organic revenue grew 4.1% in the quarter ended 30 September 2026, against 3.0% in the second quarter, per Blackbaud's 28 October 2026 results release. Recurring revenue was $287.0 million, 98.1% of the total.
  • Margins widened. Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) was $111.1 million in the third quarter, a 38.0% margin, up 260 basis points from a year earlier. Non-GAAP free cash flow was $126.0 million, a 43.1% margin, per the Form 8-K exhibit.
  • The upper-half outlook survived the report. On 28 October 2026 Blackbaud reaffirmed adjusted EBITDA of $430–438 million, non-GAAP EPS of $5.15–$5.25 and free cash flow of $280–290 million. It expects the upper half of all four ranges and of the revenue range.
  • Buybacks keep shrinking the share count. Shares outstanding fell to 45,102,406 on 30 September 2026 from 46,705,325 on 31 December 2025. The 2026 repurchase outlook is 7% to 10% of year-end 2025 shares, and about $832 million of authorization remained.
  • Debt is falling. Chief Financial Officer Chad Anderson said the leverage ratio fell to 2.3 times in the third quarter from 2.7 times in the first. Total debt was about $1.04 billion on 30 September 2026.

Bear case

  • A larger renewal cohort slows contract growth. On the 28 October 2026 call, management said the 2026 contractual recurring revenue renewal cohort is about 40% larger than 2025's. It expects that to moderate contractual recurring growth through the first half of 2027, per Quartr's call summary.
  • Revenue missed again. Third-quarter revenue of $292.6 million trailed the $293.935 million consensus on 28 October 2026, per Benzinga. The EPS beat leaned on buybacks.
  • Guidance was reaffirmed, not raised. Benzinga showed the $5.15–$5.25 EPS range against a $5.25 consensus estimate on 28 October 2026. The estimates already sit at the top of the range.
  • Insiders sold into the rally. Director Andrew Leitch sold 18,000 shares at an average of $53.70 on 6 November 2026, per an SEC Form 4 filed 10 November 2026. Chief Executive Michael Gianoni sold 17,000 shares at $47.35 on 25 August 2026.
  • The AI products have no reported revenue. The third-quarter release says Lantern, the fundraising language model built with Databricks, will be embedded in the platform starting in 2027. It gave no AI adoption or revenue figures.

Price setup

Blackbaud closed at $53.56 on 12 November 2026. That is 17.4% below the 52-week intraday high of $64.84 set on 17 December 2025. It is 18.4% above the three-month reference close of $45.25 on 14 August 2026.

The shares closed at $55.80 on 5 November 2026, $54.12 on 6 November 2026 and $54.92 on 10 November 2026, then slipped to $54.40 and $53.56. They did not rise after the 28 October 2026 report. The 50-day average is $48.42 and the 200-day average is $41.22, both as of 12 November 2026. The 52-week closing low was $26.54 on 22 June 2026.

The company issued no stock into the rally and is retiring shares. Retail attention is hard to measure, because "BLKB" also tags a Swiss cantonal bank in news feeds. The next scheduled report is about three months away.

Catalysts ahead

  • ~10 February 2027 (est.): Fourth-quarter 2026 results and first 2027 guidance (date estimated from the 10 February 2026 precedent). Shows whether Blackbaud finished 2026 in the upper half of its ranges and how much the 40% larger renewal cohort slows 2027 organic growth.

What would change the view

A daily close above $64.30, just under the 52-week intraday high of $64.84 on 17 December 2025, which would show the shares leading the S&P 500. Fourth-quarter 2026 organic revenue growth above the 4.1% of the third quarter, with a 2027 revenue guide faster than 2026, would also show it.

What it trades with

Blackbaud trades with mid-cap cloud software. Its customers are nonprofits, schools and healthcare foundations, so charitable-giving trends and nonprofit budgets feed into renewals. About $1.04 billion of debt on 30 September 2026 links the shares to interest-rate moves.

News keyed on "BLKB" often concerns Basellandschaftliche Kantonalbank. A parliamentary commission pushed its final report on that bank to the second quarter of 2027, per a 28 October 2026 fiscal.ai item. Those items have no bearing on Blackbaud.

The evidence, claim by claim (8)
  1. Third-quarter 2026 revenue was $292.6 million; non-GAAP organic revenue grew 4.1%; recurring revenue was $287.0 million, 98.1% of the total. Blackbaud third-quarter 2026 results, Form 8-K Exhibit 99.1 · as of
  2. Third-quarter non-GAAP EPS of $1.36 beat the $1.33 estimate; revenue of $292.641 million missed the $293.935 million estimate. Benzinga, 28 October 2026 · as of
  3. Blackbaud reaffirmed 2026 revenue of $1.173–1.179 billion, adjusted EBITDA of $430–438 million, non-GAAP EPS of $5.15–$5.25 and free cash flow of $280–290 million, and expects the upper half of all four. Blackbaud third-quarter 2026 results, Form 8-K Exhibit 99.1 · as of
  4. Third-quarter adjusted EBITDA was $111.1 million, a 38.0% margin, up 260 basis points; non-GAAP free cash flow was $126.0 million, a 43.1% margin. Blackbaud third-quarter 2026 results, Form 8-K Exhibit 99.1 · as of
  5. Shares outstanding fell to 45,102,406 from 46,705,325 at 31 December 2025; the 2026 repurchase outlook is 7% to 10% of year-end 2025 shares; about $832 million of authorization remained. Blackbaud third-quarter 2026 results, Form 8-K Exhibit 99.1 · as of
  6. Management said the 2026 contractual recurring revenue renewal cohort is about 40% larger than 2025's and will moderate contractual recurring growth through the first half of 2027. Third-quarter 2026 earnings call, Quartr summary · as of
  7. Director Andrew Leitch sold 18,000 shares in the open market at an average of $53.70 on 6 November 2026. SEC Form 4 filed 10 November 2026 · as of
  8. Blackbaud reported fourth-quarter and full-year 2025 results and 2026 guidance on 10 February 2026, the precedent for the timing of the next annual report. Blackbaud date announcement, 27 January 2026 · as of

Sources

Related · shared themes

See also · stocks to watch

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X